Related Experiment Videos
HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and
Siddhesh Kolambkar1, Mansi Tomar2, Nazneen Arif3
1Department of Community Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.
Abstract:
Cervical cancer remains a major public health concern in the WHO South-East Asia Region (SEAR), where human papillomavirus (HPV) vaccination coverage remains uneven. This scoping review synthesizes evidence on HPV vaccine uptake and implementation strategies and challenges across SEAR countries. Following the Arksey and O'Malley framework and PRISMA-Scoping Review (ScR) guidelines, 46 studies published between January 2003 and February 2026 were analyzed. Ten of eleven SEAR countries have introduced HPV vaccination nationally, with Bhutan, Sri Lanka, and Thailand achieving coverage above 90%, while several countries remain in early implementation or expansion phases. Four cross-cutting barriers were identified: policy and financial constraints, sociocultural resistance, weak health-system capacity, and vaccine hesitancy. Based on these findings, SEAR-HPV Integrated Implementation Model (SHIM) is proposed to strengthen policy support, sustainable financing, community engagement, workforce preparedness, and digital monitoring. This review highlights evidence-informed strategies to accelerate HPV vaccine scale-up and advance cervical cancer elimination goals in the region.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Vaccinations
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Vaccines
Respiratory Syncytial Virus Disease